Trulieve Cannabis Corp.
TCNNFOTCHealthcare● Active
$13.00
+$1.26(+10.73%)
Market Cap$2.5B
P/E Ratio—
52W High$13
52W Low$3.25
Trulieve Cannabis Corp. (TCNNF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
TCNNF · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
$0.01
Est. -$0.01 · +170.8%
Revenue
$0.29B
Est. $0.28B · +0.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
TCNNF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.04 | — | — | — | $0.29B | — |
| ▲ Q2 FY2026 | May 7, 2026 | -$0.01 | $0.01 | +170.8% | $0.29B | $0.28B | +0.7% |
| ▼ Q1 FY2026 | Feb 26, 2026 | -$0.07 | -$0.22 | -196.2% | $0.29B | $0.30B | -1.8% |
| ▼ Q3 FY2025 | Aug 6, 2025 | -$0.07 | -$0.07 | -7.6% | $0.30B | $0.29B | +5.2% |
| ▼ Q2 FY2025 | May 7, 2025 | -$0.08 | -$0.17 | -112.5% | $0.30B | $0.30B | -2.1% |
| ▼ Q1 FY2025 | Feb 26, 2025 | -$0.18 | -$0.27 | -50.0% | $0.30B | $0.29B | +3.0% |
| ▼ Q4 FY2024 | Nov 5, 2024 | -$0.13 | -$0.33 | -153.8% | $0.28B | $0.29B | -2.8% |
| ▲ Q3 FY2024 | Aug 6, 2024 | -$0.08 | -$0.06 | +25.0% | $0.30B | $0.29B | +3.3% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.04
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
$0.01
EPS Est.
-$0.01
EPS Surpr.
+170.8%
Revenue
$0.29B
Q1 FY2026
Feb 26, 2026Miss
EPS Actual
-$0.22
EPS Est.
-$0.07
EPS Surpr.
-196.2%
Revenue
$0.29B
Q3 FY2025
Aug 6, 2025Miss
EPS Actual
-$0.07
EPS Est.
-$0.07
EPS Surpr.
-7.6%
Revenue
$0.30B
Q2 FY2025
May 7, 2025Miss
EPS Actual
-$0.17
EPS Est.
-$0.08
EPS Surpr.
-112.5%
Revenue
$0.30B
Q1 FY2025
Feb 26, 2025Miss
EPS Actual
-$0.27
EPS Est.
-$0.18
EPS Surpr.
-50.0%
Revenue
$0.30B
Q4 FY2024
Nov 5, 2024Miss
EPS Actual
-$0.33
EPS Est.
-$0.13
EPS Surpr.
-153.8%
Revenue
$0.28B
Q3 FY2024
Aug 6, 2024Beat
EPS Actual
-$0.06
EPS Est.
-$0.08
EPS Surpr.
+25.0%
Revenue
$0.30B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.04 | $0.04 | $0.04 | 1 |
| Q3 FY2027 | $0.03 | $0.03 | $0.03 | 1 |
| Q2 FY2027 | $0.03 | $0.03 | $0.03 | 1 |
| Q1 FY2027 | $0.02 | $0.02 | $0.02 | 1 |
| Q4 FY2026 | $0.04 | $0.04 | $0.04 | 1 |
| Q3 FY2026 | $0.03 | $0.03 | $0.03 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.3B | $0.3B | $0.3B | 3 |
| Q3 FY2027 | $0.3B | $0.3B | $0.3B | 2 |
| Q2 FY2027 | $0.3B | $0.3B | $0.3B | 2 |
| Q1 FY2027 | $0.3B | $0.3B | $0.3B | 3 |
| Q4 FY2026 | $0.3B | $0.3B | $0.3B | 3 |
| Q3 FY2026 | $0.3B | $0.3B | $0.3B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +170.8% | $9.79 | $9.38 | -4.19% |
| ▼ Q1 FY2026 | Feb 26, 2026 | -196.2% | $6.40 | $6.50 | +1.56% |
| ▼ Q3 FY2025 | Aug 6, 2025 | -7.6% | $5.55 | $5.28 | -4.86% |
| ▼ Q2 FY2025 | May 7, 2025 | -112.5% | $4.47 | $4.36 | -2.46% |
| ▼ Q1 FY2025 | Feb 26, 2025 | -50.0% | $4.11 | $4.12 | +0.24% |
| ▼ Q4 FY2024 | Nov 5, 2024 | -153.8% | $12.70 | $11.65 | -8.27% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +25.0% | $8.65 | $9.73 | +12.49% |
| ▼ Q2 FY2024 | May 9, 2024 | -20.0% | $10.79 | $11.65 | +7.97% |
Q2 FY2026-4.19%
Report Date
May 7, 2026
EPS Beat/Miss
+170.8%
Price Before
$9.79
Price After
$9.38
Q1 FY2026+1.56%
Report Date
Feb 26, 2026
EPS Beat/Miss
-196.2%
Price Before
$6.40
Price After
$6.50
Q3 FY2025-4.86%
Report Date
Aug 6, 2025
EPS Beat/Miss
-7.6%
Price Before
$5.55
Price After
$5.28
Q2 FY2025-2.46%
Report Date
May 7, 2025
EPS Beat/Miss
-112.5%
Price Before
$4.47
Price After
$4.36
Q1 FY2025+0.24%
Report Date
Feb 26, 2025
EPS Beat/Miss
-50.0%
Price Before
$4.11
Price After
$4.12
Q4 FY2024-8.27%
Report Date
Nov 5, 2024
EPS Beat/Miss
-153.8%
Price Before
$12.70
Price After
$11.65
Q3 FY2024+12.49%
Report Date
Aug 6, 2024
EPS Beat/Miss
+25.0%
Price Before
$8.65
Price After
$9.73
Q2 FY2024+7.97%
Report Date
May 9, 2024
EPS Beat/Miss
-20.0%
Price Before
$10.79
Price After
$11.65
Avg Beat Reaction+4.15%
Avg Miss Reaction-0.97%
Beat Rate2 / 8 quarters
Largest Move+12.49% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: TCNNF ends December
Trulieve Cannabis Corp. (TCNNF) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $0.01 — beating the analyst consensus of $-0.01 by +170.8%. The next TCNNF earnings date is expected around September 1, 2026.
Each quarter, investors track TCNNF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. TCNNF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
TCNNF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
TCNNF earnings · 5 questionsTrulieve Cannabis Corp.'s next earnings report is expected around September 1, 2026. TCNNF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; TCNNF historically reports after market close (AMC).
TCNNF earnings datewhen is TCNNF earningsTCNNF next earnings datewhen does TCNNF report earningsTCNNF earnings calendar
▸ Source: FMP · Trulieve Cannabis Corp. SEC filings · US GAAP · Trulieve Cannabis Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026